Filing Details
- Accession Number:
- 0001127602-23-012691
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-06 18:37:14
- Reporting Period:
- 2023-04-04
- Accepted Time:
- 2023-04-06 18:37:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875045 | Biogen Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1769608 | Priya Singhal | 225 Binney Cambridge MA 02142 | Head Of Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-04-04 | 91 | $277.11 | 2,843 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Includes 91.6992 shares acquired under the Biogen Inc. employee stock purchase plan.